Approval · Notice of Compliance 3911 · 1997
PRINIVIL: Notice of Compliance 3911
Issued June 27, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3911
- Date
- June 27, 1997
- Company
- Merck Frosst Canada Inc.Kirkland, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for the treatment following acute myocardial infarction
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRINIVIL | Not yet assigned | — |
Medicinal ingredients
- LISINOPRIL 5 MG per TAB
- LISINOPRIL 10 MG per TAB
- LISINOPRIL 20 MG per TAB
- LISINOPRIL 40 MG per TAB
- LISINOPRIL 80 MG per TAB